Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumors 66 Advanced Solid Tumor 56 Solid Tumor 42 Solid Tumors 40 Mesothelioma 38 Mesothelioma, Malignant 34 Hematopoietic and Lymphatic System Neoplasm 23 Solid Tumor, Adult 14 Ovarian Neoplasms 13 Malignant Solid Neoplasm 13 Carcinoma, Non-Small-Cell Lung 13 Pancreatic Neoplasms 11 Melanoma 11 Sarcoma 10 Retinoblastoma 9 Colorectal Neoplasms 9 Stomach Neoplasms 8 Lung Neoplasms 8 Solid Tumours 7 Small Cell Lung Carcinoma 7 Advanced Malignant Solid Neoplasm 7 Kidney Neoplasms 6 Cholangiocarcinoma 6 Carcinoma, Renal Cell 6 Advanced/Metastatic Solid Tumors 6 Advanced or Metastatic Solid Tumors 6 Uterine Cervical Neoplasms 5 Urinary Bladder Neoplasms 5 Triple Negative Breast Neoplasms 5 Neoplasms 5

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

TMB-H × Other solid neoplasm × 90 days × Clear all

NCT06365840 2026-04-17

TMB-H

ImmuneOncia Therapeutics Inc.

Phase 2 Recruiting

Other solid neoplasm

TMB-H

Data powered by HemOnc (CC BY 4.0) Colophon ⚡